Jacobs Levy Equity Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Jacobs Levy Equity Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-19,107	Closed	-$113K	–	1143
2020 Q3	$113K	Sell	19,107 -140,517	-88%	-$695K	﹤0.01%	994
2020 Q2	$822K	Sell	159,624 -24,905	-13%	-$157K	0.01%	708
2020 Q1	$668K	Buy	184,529 +39,104	+27%	+$194K	0.01%	708
2019 Q4	$908K	Buy	+145,425	New	+$1.07M	0.01%	705
2017 Q2	–	Sell	-7,140	Closed	-$42K	–	1055
2017 Q1	$42K	Sell	7,140 -21,813	-75%	-$158K	﹤0.01%	899
2016 Q4	$156K	Sell	28,953 -1,660	-5%	-$11.1K	﹤0.01%	856
2016 Q3	$272K	Buy	30,613 +1,690	+6%	+$15.9K	﹤0.01%	833
2016 Q2	$278K	Hold	28,923	–	–	0.01%	904
2016 Q1	$266K	Sell	28,923 -7,658	-21%	-$75.8K	0.01%	906
2015 Q4	$461K	Buy	36,581 +32,071	+711%	+$381K	0.01%	568
2015 Q3	$55K	Buy	4,510 +1,000	+28%	+$14.5K	﹤0.01%	786
2015 Q2	$61K	Sell	3,510 -9,572	-73%	-$172K	﹤0.01%	779
2015 Q1	$190K	Buy	13,082 +4,502	+52%	+$49.2K	﹤0.01%	708
2014 Q4	$72K	Sell	8,580 -12,949	-60%	-$118K	﹤0.01%	793
2014 Q3	$239K	Buy	+21,529	New	+$274K	﹤0.01%	722

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jacobs Levy Equity Management's AVEO Position: Q4 2020 in Review

Jacobs Levy Equity Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2020, closing a stake of 19,107 shares — an estimated $113K sold.

Jacobs Levy Equity Management first reported a position in AVEO in Q3 2014 and held it in 15 quarters. The position peaked at $908K in Q4 2019. 65 funds tracked by Wall St. Rank hold AVEO as of Q4 2020.

Jacobs Levy Equity Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Jacobs Levy Equity Management sold 19,107 AVEO Pharmaceuticals, Inc. shares in Q4 2020, an estimated $113K.
Jacobs Levy Equity Management first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2014 and held it in 15 quarters.
Jacobs Levy Equity Management's AVEO Pharmaceuticals, Inc. position peaked at $908K in Q4 2019.
65 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2020, filed 16 Feb 2021.